How many 8-K filings has Osr Holdings, Inc. filed?

Osr Holdings, Inc. (OSRHW) has 37 8-K (Current Event Report) filings on record, spanning Feb 2024 to Nov 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Osr Holdings, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Osr Holdings, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Osr Holdings, Inc. (OSRHW) — 8-K Filings

All 8-K filings from Osr Holdings, Inc.. Browse 37 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (37)

OSR Holdings Files 8-K: Regulation FD, Other Events — Nov 25, 2025 Risk: low
OSR Holdings, Inc. filed an 8-K on November 25, 2025, reporting events as of November 21, 2025. The filing indicates a Regulation FD Disclosure and Other Events
OSR Holdings, Inc. Files 8-K — Oct 16, 2025 Risk: low
OSR Holdings, Inc. (formerly Bellevue Life Sciences Acquisition Corp.) filed an 8-K on October 16, 2025, reporting on a material definitive agreement, Regulatio
OSR Holdings Files 8-K on Security Holder Votes — Sep 23, 2025 Risk: low
OSR Holdings, Inc. filed an 8-K on September 23, 2025, reporting on matters submitted to a vote of security holders as of September 17, 2025. The company, forme
OSR Holdings Files 8-K for Other Events — Sep 9, 2025 Risk: low
OSR Holdings, Inc. filed an 8-K on September 9, 2025, reporting an event that occurred on September 3, 2025. The filing pertains to "Other Events" and does not
OSR Holdings Enters Material Definitive Agreement — Aug 20, 2025 Risk: medium
OSR Holdings, Inc. filed an 8-K on August 20, 2025, reporting an entry into a material definitive agreement on August 10, 2025. The company, formerly known as B
OSR Holdings Files 8-K: Regulation FD & Financials — Aug 6, 2025 Risk: low
OSR Holdings, Inc. filed an 8-K on August 6, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Be
OSR Holdings Files 8-K: Other Events & Financials — Jul 25, 2025 Risk: low
OSR Holdings, Inc. filed an 8-K on July 25, 2025, reporting an "Other Event" and "Financial Statements and Exhibits" as of July 24, 2025. The company, formerly
OSR Holdings Announces Director and Officer Changes — Jul 2, 2025 Risk: medium
OSR Holdings, Inc. announced on June 26, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of ce
OSR Holdings, Inc. Files 8-K for Material Agreement — May 12, 2025 Risk: medium
OSR Holdings, Inc. (formerly Bellevue Life Sciences Acquisition Corp.) filed an 8-K on May 12, 2025, reporting a material definitive agreement entered into on M
OSR Holdings Inc. Reports Board and Executive Compensation Changes — Mar 25, 2025 Risk: medium
OSR Holdings, Inc. announced on March 24, 2025, a change in its board of directors and executive compensation arrangements. The filing details the departure of
OSR Holdings, Inc. Files 8-K with Material Agreement — Feb 28, 2025 Risk: medium
OSR Holdings, Inc. entered into a material definitive agreement on February 25, 2025. The company also reported on unregistered sales of equity securities and f
OSR Holdings Completes Acquisition of 08 Industrial Applications — Feb 21, 2025 Risk: medium
OSR Holdings, Inc. announced the completion of its acquisition of 08 Industrial Applications and Services on February 14, 2025. This transaction involved a mate
OSR Holdings, Inc. Files 8-K Detailing Corporate Structure — Feb 18, 2025 Risk: low
OSR Holdings, Inc. filed an 8-K on February 18, 2025, reporting events as of February 14, 2025. The filing details the company's structure, including its common
Bellevue Life Sciences Acquisition Corp. Files 8-K — Feb 13, 2025 Risk: low
Bellevue Life Sciences Acquisition Corp. filed an 8-K on February 13, 2025, reporting on amendments to its articles of incorporation or bylaws, submission of ma
Bellevue Life Sciences Acquisition Corp. Files 8-K — Jan 23, 2025 Risk: medium
Bellevue Life Sciences Acquisition Corp. (BLAC) filed an 8-K on January 23, 2025, reporting the entry into a material definitive agreement. The filing also deta
Bellevue Life Sciences Unit Agreement Filed — Jan 10, 2025 Risk: low
On January 9, 2025, Bellevue Life Sciences Acquisition Corp. (BLACU) entered into a material definitive agreement related to its units. The company's units cons
Bellevue Life Sciences Files 8-K on Definitive Agreement — Dec 23, 2024 Risk: medium
Bellevue Life Sciences Acquisition Corp. filed an 8-K on December 23, 2024, reporting a material definitive agreement entered into on December 17, 2024. The fil
Bellevue Life Sciences Acquisition Corp. Files 8-K — Nov 12, 2024 Risk: low
Bellevue Life Sciences Acquisition Corp. filed an 8-K on November 12, 2024, reporting on various corporate events. The filing details amendments to its articles
Bellevue Life Sciences Acquisition Corp. Files 8-K — Oct 22, 2024 Risk: medium
On October 16, 2024, Bellevue Life Sciences Acquisition Corp. entered into a material definitive agreement. This filing also indicates the creation of a direct
Bellevue Life Sciences Acquisition Corp. Files 8-K — Oct 15, 2024 Risk: medium
Bellevue Life Sciences Acquisition Corp. (BLACU) entered into a material definitive agreement on October 10, 2024. This filing also indicates the creation of a
Bellevue Life Sciences Faces Delisting Notice — Oct 10, 2024 Risk: high
Bellevue Life Sciences Acquisition Corp. filed an 8-K on October 10, 2024, reporting a notice of delisting or failure to satisfy continued listing rules as of O
Bellevue Life Sciences Acquisition Corp. Files 8-K — Sep 24, 2024 Risk: medium
Bellevue Life Sciences Acquisition Corp. entered into a material definitive agreement on September 20, 2024. This filing also indicates the creation of a direct
Bellevue Life Sciences Acquisition Corp. Files 8-K — Sep 16, 2024 Risk: low
Bellevue Life Sciences Acquisition Corp. filed an 8-K on September 16, 2024, reporting an event on September 10, 2024. The filing details the company's structur
Bellevue Life Sciences Faces Delisting Notice — Aug 22, 2024 Risk: high
Bellevue Life Sciences Acquisition Corp. filed an 8-K on August 22, 2024, reporting a notice of delisting or failure to meet continued listing standards as of A
Bellevue Life Sciences Acquisition Corp. 8-K Filing — Aug 16, 2024 Risk: low
Bellevue Life Sciences Acquisition Corp. filed an 8-K on August 16, 2024, reporting an event on August 13, 2024. The filing details the company's structure, inc
Bellevue Life Sciences Acquisition Corp. Files 8-K — Jul 16, 2024 Risk: low
Bellevue Life Sciences Acquisition Corp. filed an 8-K on July 16, 2024, reporting a material definitive agreement and other events as of July 11, 2024. The fili
Bellevue Life Sciences Acquisition Corp. Files 8-K — Jun 27, 2024 Risk: low
Bellevue Life Sciences Acquisition Corp. filed an 8-K on June 27, 2024, reporting events as of June 23, 2024. The filing pertains to the departure of directors,
Bellevue Life Sciences Faces Delisting, Board Changes — Jun 13, 2024 Risk: high
Bellevue Life Sciences Acquisition Corp. filed an 8-K on June 13, 2024, reporting a departure of directors and officers, election of new directors, and appointm
Bellevue Life Sciences 8-K: Material Agreements & Officer Changes — May 30, 2024 Risk: low
Bellevue Life Sciences Acquisition Corp. filed an 8-K on May 30, 2024, reporting on material definitive agreements and changes in directors/officers as of May 2
Bellevue Life Sciences Acquisition Corp. Files 8-K — May 14, 2024 Risk: medium
Bellevue Life Sciences Acquisition Corp. filed an 8-K on May 14, 2024, to report several material events. These include entering into a definitive agreement, cr
Bellevue Life Sciences Unit Structure Detailed — May 13, 2024 Risk: low
Bellevue Life Sciences Acquisition Corp. filed an 8-K on May 13, 2024, reporting on its structure. The company's units consist of one share of common stock, one
Bellevue Life Sciences Acquisition Corp. Files 8-K — May 10, 2024 Risk: low
Bellevue Life Sciences Acquisition Corp. filed an 8-K on May 10, 2024, reporting an "Other Event." The filing details the company's structure, including units c
Bellevue Life Sciences Faces Delisting Concerns — Apr 22, 2024 Risk: high
Bellevue Life Sciences Acquisition Corp. filed an 8-K on April 22, 2024, reporting a material definitive agreement and a direct financial obligation. The filing
Bellevue Life Sciences Warrants Exercisable at $11.50 — Apr 11, 2024 Risk: medium
Bellevue Life Sciences Acquisition Corp. announced on April 8, 2024, that its redeemable warrants are now exercisable for shares of common stock at an exercise
Bellevue Life Sciences Warrants Exercisable at $11.50 — Mar 13, 2024 Risk: medium
Bellevue Life Sciences Acquisition Corp. announced on March 8, 2024, that its redeemable warrants are now exercisable for shares of common stock at an exercise
Bellevue Life Sciences Delisted from Nasdaq, Moves to OTC Pink — Feb 21, 2024 Risk: high
Bellevue Life Sciences Acquisition Corp. (BLACU) announced on February 15, 2024, that it received a delisting notice from Nasdaq due to its failure to maintain
Bellevue Life Sciences Reports Material Agreement, New Obligation, Charter Changes — Feb 13, 2024 Risk: medium
Bellevue Life Sciences Acquisition Corp. filed an 8-K on February 13, 2024, reporting events that occurred on February 9, 2024. The filing indicates the company

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX